No headlines found.
Inspire Named to Inc.'s 2026 List of Fastest-Growing Private Companies in the Rocky Mountains
PRNewswire (Wed, 1-Apr 6:02 AM ET)
Inspire Surpasses $4 Billion in Assets Under Management
PRNewswire (Wed, 28-Jan 1:06 PM ET)
Inspire Corporate Bond ETF (IBD) invests in the investment grade bonds of inspiring, biblically aligned large companies ($13B+ market cap) from the United States. IBD is managed according to biblically responsible investing standards seeking to create meaningful impact in the world and help investors align their investments to support biblical values. The Inspire Corporate Bond ETF seeks to replicate investment results that generally correspond, before fees and expenses, to the performance of the Inspire Corporate Bond Impact Equal Weight Index.
Inspire Corporate Bond ETF trades on the ARCA stock market under the symbol IBD.
As of April 9, 2026, IBD stock price declined to $23.91 with 7,860 million shares trading.
IBD has a beta of -0.05, meaning it tends to be less sensitive to market movements. IBD has a correlation of 0.03 to the broad based SPY ETF.
IBD has a market cap of $487.76 million. This is considered a Small Cap stock.
In the last 3 years, IBD traded as high as $25.49 and as low as $21.95.
IBD has underperformed the market in the last year with a price return of +6.8% while the SPY ETF gained +37.4%. However, in the short term, IBD had mixed performance relative to the market. It has outperformed in the last 3 months, returning 0.0% vs -1.9% return in SPY. But in the last 2 weeks, IBD shares have been beat by the market, returning +0.8% compared to an SPY return of +2.8%.
IBD support price is $23.75 and resistance is $24.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IBD shares will trade within this expected range on the day.
